FDA Determines Certain Drug Products Were Not Withdrawn for Safety or Effectiveness
May 09, 2025
May 09, 2025
WASHINGTON, May 9 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration (FDA) has made a significant determination regarding several drug products, including VOSOL (Acetic Acid, Glacial) 2% Otic Solution/Drops, and others in a range of therapeutic categories.
The agency confirmed that these products were not withdrawn from sale for reasons of safety or effectiveness. As a result of this decision, the FDA will not initiate withdrawal procedures for . . .
The agency confirmed that these products were not withdrawn from sale for reasons of safety or effectiveness. As a result of this decision, the FDA will not initiate withdrawal procedures for . . .